Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FK91U
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,715
Award facts
- Contract value 100% obligated
- $34,715.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,715 to DMS Pharmaceutical Group Inc. for Nexplanon 68 mg implants, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor, with performance taking place at its facility in Park Ridge, IL. The company has been registered in SAM.gov since 2001 and specializes in supplying comprehensive pharmaceutical products and medical devices to federal agencies, particularly the Department of Defense healthcare system.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The underlying IDC covers an extensive portfolio of pharmaceutical items supporting medical supply needs for military health facilities worldwide, including prescription medications, biologics, medical consumables, and specialty pharmaceutical products. Nexplanon implants, a contraceptive device being delivered under this order, exemplifies the diverse range of medical products the contractor provides to DoD healthcare facilities. The company's consistent success in securing delivery orders demonstrates its established position as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FK91U?
SPE2DB25FK91U was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FK91U worth?
The government has obligated $34,715 on SPE2DB25FK91U.
Is contract SPE2DB25FK91U an order under another contract?
Yes. SPE2DB25FK91U is a delivery order under SPE2DB20D9202, an indefinite delivery contract.
Was contract SPE2DB25FK91U competed?
The extent of competition for SPE2DB25FK91U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award